Zhao M, Feng L, & Li W. (2024). Network Pharmacology and Experimental Verification: SanQi-DanShen Treats Coronary Heart Disease by Inhibiting the PI3K/AKT Signaling Pathway. Dove Medical Press.
Chicago Style (17th ed.) CitationZhao M, Feng L, and Li W. Network Pharmacology and Experimental Verification: SanQi-DanShen Treats Coronary Heart Disease by Inhibiting the PI3K/AKT Signaling Pathway. Dove Medical Press, 2024.
MLA (9th ed.) CitationZhao M, et al. Network Pharmacology and Experimental Verification: SanQi-DanShen Treats Coronary Heart Disease by Inhibiting the PI3K/AKT Signaling Pathway. Dove Medical Press, 2024.
Warning: These citations may not always be 100% accurate.